Prognostic value of myocardial perfusion gated SPECT in patients with symptomatic intracranial large-artery atherosclerosis

Cerebrovascular Diseases

Volumn 24, Issue 2-3, 2007, Pages 247-254

  Candell Riera, J ^a   Arenillas, J F ^a   Romero Farina, G ^a   Aguade Bruix S ^a   De Leon G ^a   Castell Conesa, J ^a   Molina, C A ^a   Rovira, A ^a   Alvarez Sabin J ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Gated single photon emission computed tomography; Intracranial atherosclerosis; Intracranial stenosis; Myocardial ischemia

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; BRAIN ARTERY; BRAIN ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART DISEASE; HEART PERFUSION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; KAPLAN MEIER METHOD; MALE; NEUROIMAGING; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURVIVAL;

AGED; CEREBROVASCULAR ACCIDENT; CONSTRICTION, PATHOLOGIC; CORONARY CIRCULATION; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HEART DISEASES; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; ISCHEMIC ATTACK, TRANSIENT; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 34548101972     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000104486     Document Type: Article

References (23)

1. Hartmann A, Rundek T, Mast H, Paik MC, Boden-Albala B, Mohr JP, Sacco RL: Mortality and causes of death after first ischemic stroke: the Northern Manhattan Stroke Study. Neurology 2001;57:2000-2005.
2. Toole JF, Yuson CP, Janeway R, Johnston F, Davis C, Cordell AR, Howard G: Transient ischemic attacks: a prospective study of 225 patients. Neurology 1978;28:746-753.
3. Muuronen A, Kaste M: Outcome of 314 patients with transient ischemic attacks. Stroke 1982;13:24-31.
4. Arenillas JF, Molina CA, Montaner J, Abilleira S, González- Sánchez M, Álvarez-Sabín J: Progression and clinical recurrence of symptomatic middle cerebral artery stenosis: a long-term follow-up transcranial Doppler ultrasound study. Stroke 2001;32:2898-2904.
5. Adams RJ, Chimowitz MI, Alpert JS, Awad IA, Cerqueria MD, Fayad P, Taubert KA, American Heart Association/American Stroke Association: Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association. Stroke 2003;34:2310-2322.
6. Di Pasquale G, Andreoli A, Pinelli G, Grazi P, Manini G, Tognetti F, Testa C: Cerebral ischemia and asymptomatic coronary artery disease: a prospective study of 83 patients. Stroke 1986;17:1098-1101.
7. Chimowitz MI, Poole RM, Starling MR, Schwaiger M, Gross MD: Frequency and severity of asymptomatic coronary disease in patients with different causes of stroke. Stroke 1997;28:941-945.
8. Urbinati S, Di Pasquale G, Andreoli A, Lusa AM, Ruffini M, Lanzino G, Pinelli G: Frequency and prognostic significance of silent coronary artery disease in patients with cerebral ischemia undergoing carotid endarterectomy. Am J Cardiol 1992;69:1166-1170.
9. Sacco RL, Kargman DE, Gu Q, Zamanillo MC: Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke 1995;26:14-20.
10. Wityk RJ, Lehman D, Klag M, Coresh J, Ahn H, Litt B: Race and sex differences in the distribution of cerebral atherosclerosis. Stroke 1996;27:1974-1980.
11. Arenillas JF, Alvarez-Sabin J, Molina CA, Chacon P, Montaner J, Rovira A, Ibarra B, Quintana M: C-reactive protein predicts further ischemic events in first-ever transient ischemic attack or stroke patients with intracranial large-artery occlusive disease. Stroke 2003;34:2463-2468.
12. Arenillas JF, Candell-Riera J, Romero-Farina G, Molina CA, Chacon P, Aguade-Bruix S, Montaner J, de Leon G, Castell-Conesa J, Alvarez-Sabin J: Silent myocardial ischemia in patients with symptomatic intracranial atherosclerosis: associated factors. Stroke 2005;36:1201-1206.
13. 99mTc-MIBI SPECT: improved diagnostic yield in coronary artery disease. J Am Coll Cardiol 1997;29:531-536.
14. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS: Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105:539-542.
15. Kubo S, Tadamura E, Kudoh T, Inubushi M, Ikeda T, Koshiji T, Nishimura K, Komeda M, Tamaki N, Konishi J: Assessment of the effect of revascularization early after CABG using ECG-gated perfusion single-photon emission tomography. Eur J Nucl Med 2001;28:230-239.
16. Emmett L, Iwanochko RM, Freeman MR, Barolet A, Lee DS, Husain M: Reversible regional wall motion abnormalities on exercise technetium-99m-gated cardiac single photon emission computed tomography predict high-grade angiographic stenoses. J Am Coll Cardiol 2002;39:991-998.
17. Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzanti M, Su HT, Van Train KF, Berman DS: Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 1995;36:2138-2147.
18. Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Kasner SE, Benesch CG, Sila CA, Jovin TG, Romano JG, Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators: Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005;352:1305-1316.
19. Mitchell JRA, Schwartz CJ: Relationship between arterial disease in different sites. Br Med J 1962;i:1293-1301.
20. Solberg LA, McGarry PA, Moosy J: Severity of atherosclerosis in cerebral arteries, coronary arteries, and aortas. Ann NY Acad Sci 1968;149:956-973.
21. Lekakis JP, Papamichael CM, Cimponeriu AT, Stamatelopoulos KS, Papaioannou TG, Kanakakis J, Alevizaki MK, Papapanagiotou A, Kalofoutis AT, Stamatelopoulos SF: Atherosclerotic changes of extracoronary arteries are associated with the extent of coronary atherosclerosis. Am J Cardiol 2000;85:949-952.
22. Urbinati S, Di Pasquale G, Andreoli A, Lusa AM, Lanzino G, Grazi P, Ruffini M, Labanti G, Pinelli G: Heart-brain interactions in cerebral ischaemia: a non-invasive cardiologic study protocol. Neurol Res 1992;14(suppl 2):112-117.
23. Lette J, Tatum JL, Fraser S, Miller DD, Waters DD, Heller G, Stanton EB, Bom HS, Leppo J, Nattel S: Safety of dipyridamole testing in 73,806 patients: the Multicenter Dipyridamole Safety Study. J Nucl Cardiol 1995;2:3-17.